GABA Agonists

"GABA Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA).

Descriptor ID

D018755

MeSH Number(s)

D27.505.519.625.240.200

D27.505.696.577.240.200

Concept/Terms

GABA Agonists

Below are MeSH descriptors whose meaning is more general than "GABA Agonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
GABA Agents [D27.505.519.625.240]
GABA Agonists [D27.505.519.625.240.200]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
GABA Agents [D27.505.696.577.240]
GABA Agonists [D27.505.696.577.240.200]

Below are MeSH descriptors whose meaning is related to "GABA Agonists".

Below are MeSH descriptors whose meaning is more specific than "GABA Agonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "GABA Agonists" by people in Harvard Catalyst Profiles by year, and whether "GABA Agonists" was a major or minor topic of these publication.

Bar chart showing 84 publications over 23 distinct years, with a maximum of 12 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	0	2	2
1998	1	4	5
1999	1	2	3
2000	3	3	6
2001	4	3	7
2002	3	5	8
2003	4	8	12
2004	1	2	3
2005	1	4	5
2006	2	3	5
2007	0	3	3
2008	1	2	3
2009	2	2	4
2010	1	2	3
2012	1	2	3
2013	1	1	2
2014	0	2	2
2015	0	1	1
2016	1	1	2
2018	1	0	1
2019	1	0	1
2020	1	1	2

Below are the most recent publications written about "GABA Agonists" by people in Profiles.

The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome. Neurology. 2021 02 16; 96(7):e1024-e1035.

View in: PubMed
Image-guided neural activity manipulation with a paramagnetic drug. Nat Commun. 2020 01 09; 11(1):136.

View in: PubMed
Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models. Cell. 2019 08 08; 178(4):867-886.e24.

View in: PubMed
Etomidate Effects on Desensitization and Deactivation of a4ß3d GABAA Receptors Inducibly Expressed in HEK293 TetR Cells. J Pharmacol Exp Ther. 2019 01; 368(1):100-105.

View in: PubMed
Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of a1ß3?2L GABAA Receptors. PLoS One. 2016; 11(4):e0154031.

View in: PubMed
Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation. J Neurosci. 2016 Feb 03; 36(5):1669-81.

View in: PubMed
Tonic Inhibitory Control of Dentate Gyrus Granule Cells by a5-Containing GABAA Receptors Reduces Memory Interference. J Neurosci. 2015 Oct 07; 35(40):13698-712.

View in: PubMed
The role of the dorsal hippocampus in two versions of the touchscreen automated paired associates learning (PAL) task for mice. Psychopharmacology (Berl). 2015 Nov; 232(21-22):3899-910.

View in: PubMed
Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology. Anesthesiology. 2014 Aug; 121(2):290-301.

View in: PubMed
Functional probes of drug-receptor interactions implicated by structural studies: Cys-loop receptors provide a fertile testing ground. J Med Chem. 2014 Aug 14; 57(15):6289-300.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Pharmacol Exp Ther
Psychopharmacology (Berl)
J Neurosci
J Clin Psychopharmacol
Anesthesiology
Br J Pharmacol
Eur J Pharmacol
Brain Res
Cochrane Database Syst Rev
Biol Psychiatry